FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 132 filers reported holding FLEXION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,141,000 | +15.3% | 91,439 | +4.5% | 0.01% | 0.0% |
Q4 2018 | $990,000 | -20.9% | 87,487 | +30.7% | 0.01% | 0.0% |
Q3 2018 | $1,252,000 | -11.3% | 66,920 | +22.5% | 0.01% | -11.1% |
Q2 2018 | $1,412,000 | +25.2% | 54,622 | +8.5% | 0.01% | 0.0% |
Q1 2018 | $1,128,000 | +8.3% | 50,350 | +21.0% | 0.01% | +28.6% |
Q4 2017 | $1,042,000 | +37.1% | 41,599 | +32.4% | 0.01% | +40.0% |
Q3 2017 | $760,000 | +31.0% | 31,423 | +9.6% | 0.01% | +25.0% |
Q2 2017 | $580,000 | -19.6% | 28,666 | +7.1% | 0.00% | -20.0% |
Q1 2017 | $721,000 | +26.7% | 26,778 | -10.5% | 0.01% | +25.0% |
Q4 2016 | $569,000 | -17.1% | 29,913 | -14.7% | 0.00% | -33.3% |
Q3 2016 | $686,000 | +51.4% | 35,084 | +15.8% | 0.01% | +50.0% |
Q2 2016 | $453,000 | +103.1% | 30,301 | +25.1% | 0.00% | +100.0% |
Q1 2016 | $223,000 | -59.2% | 24,223 | -14.6% | 0.00% | -60.0% |
Q4 2015 | $547,000 | -89.1% | 28,374 | -15.7% | 0.01% | 0.0% |
Q3 2015 | $5,001,000 | +975.5% | 33,656 | +58.3% | 0.01% | +25.0% |
Q2 2015 | $465,000 | – | 21,264 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Clearline Capital LP | 910,542 | $11,200,000 | 5.47% |
Gagnon Advisors, LLC | 401,648 | $4,940,000 | 2.82% |
MILLER VALUE PARTNERS, LLC | 4,852,460 | $59,685,000 | 2.27% |
GAGNON SECURITIES LLC | 753,794 | $9,272,000 | 2.00% |
SELZ CAPITAL LLC | 430,000 | $5,289,000 | 1.43% |
CAMPBELL CAPITAL MANAGEMENT INC | 129,622 | $1,594,000 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 928,924 | $11,426,000 | 1.12% |
Rubric Capital Management LP | 616,473 | $7,583,000 | 0.60% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,908,000 | 0.32% |
Claro Advisors LLC | 22,100 | $272,000 | 0.25% |